Add listing
    0
    Add listing

    Axalbion SA Verified listing

    • Swiss Biotech Association
      Not a member

    Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough. Axalbion’s s strategy is to develop its lead compound AX-8 up-to Phase 2b to show clinical proof of concept across a representative patient population.

    Location
    Additional address info
    • EPFL Innovation Park, Bat C
    Canton
    Facts & figures
    • Type of organization
      Private company
    • Year of foundation
      2017
    • Number of employees in Switzerland
      1-9
    Key business

    You may also be interested in